Celsion corp (CLSN)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flows from operating activities:
Net loss

-5,056

-3,102

-5,476

-5,904

-2,367

5,480

-4,656

-8,230

-4,476

-4,680

-5,671

-4,889

-5,160

-5,396

-6,409

-4,530

-5,716

-5,513

-4,267

-5,674

-7,005

-6,455

-6,942

-6,673

-5,422

-3,949

-4,071

420

-650

-8,259

-6,017

-6,104

-6,186

-6,121

-6,392

-6,944

-3,764

Adjustments to reconcile net loss to net cash from operating activities:
Depreciation and amortization

188

184

175

173

188

95

87

87

87

41

170

170

170

657

121

121

121

95

109

109

109

107

87

87

87

108

76

76

76

119

53

53

53

39

43

43

43

Change in fair value of earn-out milestone liability

-41

101

85

-127

3,130

63

4,114

-277

-270

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Fair value of warrants issued in connection with amendment to modify GEN-1 earn-out milestone payments

-

0

0

0

-400

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Recognition of deferred revenue

125

-

125

125

125

-

125

125

125

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of earn-out milestone liability

-

-

-

-

-

-

-

-

-

-

-

-

-283

1,289

-662

408

-302

-299

282

-69

-172

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash received for non-refundable research and development fee

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

5,000

-

-

-

-

-

-

-

-

Change in fair value of common stock warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,380

4,280

-

-881

-447

77

39

-375

249

168

Recognition of deferred revenue

-

-

-

-

-

-

-

-

-

-

-125

-125

-125

-125

-125

-125

-125

-125

-125

-125

-125

-125

-125

-125

-125

-125

-125

-125

-125

-

-

-

-

-

-

-

-

Change in fair value of common stock warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

18

43

-123

-96

18

-3

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation costs

451

524

453

617

691

618

614

3,217

153

153

146

687

117

179

432

283

615

232

306

461

848

331

532

1,114

607

-

-

-

-

292

293

251

305

143

332

233

326

Stock-based compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-471

-263

-

-

-

-

-

-

-

-

Shares issues in upon vesting of stock awards

-

-

-

-

-

-

-

-

-

235

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

63

0

20

-

-

-

-

-

-

-

-

Deferred income tax asset

1,819

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Shares issued in exchange for services

-

-

-

-

-

0

0

14

15

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of deferred finance charges and debt discount associated with notes payable

96

-

-

-

97

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Shares issued out of treasury

-

-

-

-

-

-

-

-

-

-

-

-

-

22

38

20

20

12

21

25

26

22

11

21

9

-

-

-

-

12

12

31

50

-55

87

15

13

Change in deferred rent liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-3

-2

65

-

-

-

0

Amortization of deferred finance charges and debt discount associated with notes payable

-

-

-

-

-

-

-

-

-

0

0

17

17

37

53

60

85

89

103

117

127

126

135

86

89

237

35

31

31

-

-

-

-

-

-

-

-

Change in deferred rent liability

-

-

-

-

-

-2

-3

-1

-1

-1

36

33

-9

-9

-9

-7

-8

-7

-7

-7

-6

-6

-6

-6

-5

-5

-5

-4

-3

-

-

-

-

-

-

-

-

Loss realized on sale of investment securities

-

-

-

-

-

-

-

-

-

-

-

-

-

3

0

0

-3

0

0

-0

0

-1

0

-44

20

-

-

-

-

-

-

-

-

-

-

-

-

Net changes in:
Accrued interest on investment securities

1

-5

-38

-12

9

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-262

216

-

-

-

-

Receivable on sale of net operating losses

1,819

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Advances, deposits and other current assets

-

-

-

-

-

-

219

49

12

54

0

0

-4

-

4

0

-26

-

-27

14

-172

3

-84

-48

127

86

-137

-58

225

-

-

-

-

-

-

-

-

Non cash dividend expense on preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

281

Advances, deposits and other current assets

64

-

-

-

645

-

-

-

-

-0

-20

-31

-62

-

-174

129

182

-

-279

-151

399

-88

200

-290

101

-

-

-

-

-

-

-

-

-

-

-1,380

1,172

Accounts payable and accrued liabilities

-504

-

462

659

-635

-

-435

601

-565

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable - trade

-

-

-

-

-

-

-

-

-

403

-959

-414

1,508

-146

76

184

-65

326

-699

-1,118

632

-949

781

1,283

649

-796

726

-2,658

1,841

-376

-1,263

596

-301

1,237

-554

10

-1,231

Other accrued liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,313

-388

730

-157

-1,460

825

-720

579

255

88

-1,735

1,298

Accrued liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

266

281

177

-

-787

312

-532

-

-97

-332

-501

-

-

-

-

-

-

-

-

-

-

-

-

Net cash (used in) operating activities:

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-4,250

-4,744

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash (used in) operating activities:

-4,975

-5,616

-4,480

-4,626

-5,535

6,086

-4,265

-4,206

-4,655

-4,208

-5,106

-4,196

-3,130

-

-

-

-

-3,899

-5,320

-5,674

-5,936

-6,509

-5,836

-4,183

-4,823

-3,466

-2,661

-5,187

1,790

-5,978

-5,254

-5,183

-5,727

-4,439

-6,905

-7,025

-4,372

Cash flows from investing activities:
Purchases of investment securities

9,940

4,491

6,058

2,027

11,251

1,399

9,862

1

5,710

12,734

0

0

0

-

-

-

-

-3

5,590

210

15,277

650

6,683

4,629

17,862

23,738

2,589

19,749

20,245

180

4,847

1,056

10,309

-

-

-

0

Proceeds from sale and maturity of investment securities

8,000

6,805

11,410

6,500

5,400

-

-

-

-

0

0

0

1,680

2,835

0

0

10,799

5,966

7,600

3,831

17,062

15,533

7,789

11,730

7,759

19,274

12,871

2,000

3,048

6,191

2,846

4,203

5,237

0

93

-0

301

Purchases of property and equipment

8

12

73

117

145

56

4

48

29

17

0

0

21

13

6

20

21

1

53

11

43

-

-

-

-

-

-

-

-

232

9

193

177

244

145

183

0

Net cash provided by investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,180

10,778

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities

-1,948

2,300

5,277

4,354

-5,996

4,274

-5,116

4,950

-5,740

-12,751

0

100

1,658

-

-

-

-

5,969

1,955

3,659

1,742

14,638

797

4,210

-10,103

-4,463

10,282

-17,757

-17,197

5,778

-2,011

2,953

-5,249

-488

-10,716

-183

301

Cash flows from financing activities:
Proceeds from sale of common stock equity, net of issuance costs

5,794

1,669

1,711

2,709

1,754

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-36

13,825

-5

-12

8,929

6,711

-

-

-

-

13,813

23,011

10,654

602

Proceeds from sale of common stock equity, net of issuance costs

-

-

-

-

-

-

-

-

1,236

9,505

4,152

-31

4,284

1,346

-1

5,430

0

-

-

-

-

-

-

-

-

-0

0

-32

13,648

-

-

-

-

0

0

0

4,324

Proceeds from exercise of common stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

2

6

174

-

-

-

-

-

-

-

-

Proceeds from exercise of common stock warrants

-

-

-

-

-

-

-

-

-

16,214

10

4,776

138

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Principal payments on note payable

-

-

-

-

-

-

-

-

-

0

0

1,489

1,106

1,070

1,038

1,002

988

953

924

898

878

0

0

0

10

4,280

460

304

14

14

13

36

46

51

31

30

29

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,428

-988

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

5,794

1,687

1,693

2,709

1,754

-378

0

9,725

1,236

25,719

4,162

3,255

3,316

-

-

-

-

-379

-1,011

6,351

-878

0

0

4,963

13,814

477

-470

8,598

20,782

6,872

3,875

4,816

-46

13,940

23,374

10,623

4,896

Decrease in cash and cash equivalents

-1,129

-1,646

2,508

2,437

-9,777

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Decrease increase in cash and cash equivalents

-

-

-

-

-

-

-

-

-9,158

8,759

-944

-840

1,845

-1,560

-8,123

-2,002

5,045

1,690

-4,376

4,336

-5,072

8,128

-5,039

4,991

-1,112

-7,451

7,149

-3,595

-5,375

6,673

-3,389

2,586

-11,023

9,012

5,752

3,415

825

Supplemental disclosures of cash flow information:
Cash (paid for) received from:
Interest paid

243

0

252

255

253

-

-

-

-

0

0

11

44

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for amounts included in measurement of lease liabilities:
Operating cash flows from lease payments

130

130

130

118

106

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash financing and investing activities
Fair value of warrants issued in connection with amendment to modify the GEN-1 earn-out milestone payments

-

0

0

0

400

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Right of use assets

-

-

-

-

1,797

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock issued in lieu of cash bonuses

498

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Realized and unrealized (gains) losses, net, on investment securities

-38

8

-60

7

56

8

25

29

-23

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest paid

-

-

-

-

-

-

-

-

-

-

-

-

-

-

108

136

165

192

218

242

264

287

287

176

141

246

142

428

-180

-

-

-

-

-

-

-

-

Interest paid

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

171

10

5

-

0

393

87